China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
0.479
-0.051 (-9.64%)
At close: Nov 4, 2024, 4:00 PM
0.460
-0.019 (-3.95%)
Pre-market: Nov 5, 2024, 6:54 AM EST
China SXT Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Nov '24 Nov 4, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Market Capitalization | 2 | 1 | 3 | 11 | 29 | 16 | |
Market Cap Growth | -67.93% | -67.93% | -73.96% | -60.15% | 83.81% | -89.90% | |
Enterprise Value | -7 | -7 | 2 | 14 | 19 | 9 | |
Last Close Price | 0.48 | 1.68 | 7.09 | 140.00 | 920.00 | 1120.20 | |
PE Ratio | - | -0.47 | -0.32 | -1.02 | -9.64 | -1.35 | |
PS Ratio | 0.22 | 0.49 | 1.50 | 4.37 | 5.97 | 3.01 | |
PB Ratio | 0.08 | 0.07 | 0.20 | 0.69 | 1.79 | 1.65 | |
P/FCF Ratio | -0.49 | -0.49 | -19.56 | 55.27 | -20.25 | 29.44 | |
P/OCF Ratio | -0.49 | -0.49 | -36.68 | 42.40 | -21.68 | 16.62 | |
EV/Sales Ratio | -3.87 | -3.87 | 0.79 | 5.37 | 3.93 | 1.77 | |
EV/EBITDA Ratio | 3.95 | 3.95 | -0.31 | -2.87 | -10.15 | -9.06 | |
EV/EBIT Ratio | 3.56 | 3.56 | -0.30 | -2.69 | -8.55 | -6.82 | |
EV/FCF Ratio | 3.85 | 3.85 | -10.28 | 67.89 | -13.33 | 17.33 | |
Debt / Equity Ratio | 0.27 | 0.27 | 0.61 | 0.65 | 0.76 | 0.72 | |
Debt / FCF Ratio | -1.91 | -1.91 | -59.17 | 52.20 | -8.65 | 12.74 | |
Asset Turnover | 0.07 | 0.07 | 0.06 | 0.08 | 0.17 | 0.26 | |
Inventory Turnover | 1.98 | 1.98 | 1.88 | 1.10 | 1.60 | 2.07 | |
Quick Ratio | 1.51 | 1.51 | 1.31 | 1.14 | 1.00 | 1.26 | |
Current Ratio | 1.60 | 1.60 | 1.35 | 1.31 | 1.25 | 1.60 | |
Return on Equity (ROE) | -21.65% | -21.65% | -38.15% | -35.42% | -21.67% | -100.32% | |
Return on Assets (ROA) | -4.96% | -4.96% | -10.42% | -9.53% | -4.88% | -4.28% | |
Return on Capital (ROIC) | -6.34% | -6.34% | -12.93% | -11.73% | -6.20% | -5.58% | |
Earnings Yield | -186.13% | -326.13% | -200.33% | -50.42% | -9.63% | -66.24% | |
FCF Yield | -116.24% | -203.68% | -5.11% | 1.81% | -4.94% | 3.40% | |
Buyback Yield / Dilution | -224.91% | -224.91% | -541.90% | -44.50% | -132.79% | -20.23% | |
Total Shareholder Return | -224.91% | -224.91% | -541.90% | -44.50% | -132.79% | -20.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.